Drugs / COVID-19 Vaccine Moderna
last change Dec 2023 re-read 3 minutes ago

COVID-19 Vaccine Moderna

Developed for
Orthocoronavirinae infectious disease

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 4 NCT04760132 Comparator Feb 2021 → Dec 2023 Orthocoronavirinae infectious disease Jens D Lundgren, MD Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as COVID-19 Vaccine Moderna ClinicalTrials.gov intervention name — accepted as the source's own label NCT04760132 ↗